Aurobindo Pharma Shares Fell 2% Despite Unit Secures WHO GMP Approval
Aurobindo Pharma Limited shares were 2% lower after the company informed over its regulatory filing that its subsidiary APL Healthcare Limited got the World Health...
Tag : GMP (good manufacturing practice)
Phase 2/3 Trial of Covaxin in the US On Hold: WHO
The US Food and Drug Administration (FDA) has suspended a Phase 2/3 clinical trial of Bharat Biotech’s COVID-19 vaccine Covaxin in the US According to...